Cargando…
PP.48 Breakthrough SARS-CoV-2 Infection and COVID-19 Disease Severity in Lung Cancer Patients
Autores principales: | Tavolacci, Sooyun, Mack, Philip C., Gomez, Jorge E., Rohs, Nicholas, Rodilla, Ananda M., De Miguel Perez, Diego, Carreño, Juan Manuel, Hsu, Chin-Yuan, Cagan, Jazz, Rolfo, Christian, Moore, Amy, Brody, Rachel I., King, Jennifer C., Gerber, David E., Henschke, Claudia I., Yankelevitz, David F., Minna, John D., Bunn, Paul, García-Sastre, Adolfo, Krammer, Florian, Shyr, Yu, Hirsch, Fred R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9957599/ http://dx.doi.org/10.1016/j.jtho.2023.01.075 |
Ejemplares similares
-
Serological Response to SARS-CoV-2 after COVID-19 Vaccination in Lung Cancer Patients: Short Review
por: Rodilla, Ananda M., et al.
Publicado: (2023) -
OA01.01 Analysis of Lung Cancer Patients Receiving SARS-CoV-2 Vaccines Revealed a Minority Subset With Poor Antibody Responses Relative to Controls
por: Gomez, J., et al.
Publicado: (2021) -
Longitudinal COVID-19-vaccination-induced antibody responses and Omicron neutralization in patients with lung cancer
por: Mack, Philip C., et al.
Publicado: (2022) -
Lung Cancer and Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Identifying Important Knowledge Gaps for Investigation
por: Rolfo, Christian, et al.
Publicado: (2022) -
OA06.03 Serological Response to SARS-CoV-2 Vaccination in Patients Lung Cancer: A Mount Sinai-Led Prospective Matched Controlled Study
por: Mack, P.C., et al.
Publicado: (2022)